Use It or Lose It: Lifestyle Interventions for Preventing Cognitive Decline

With no disease-modifying drug for Alzheimer's yet proven effective at scale, the prevention paradigm for cognitive decline has shifted toward modifiable lifestyle factors. The 2024 Lancet Commission on Dementia updated its estimate to up to 45 percent of dementia cases that could theoretically be delayed or prevented by addressing fourteen modifiable risk factors (up from 40 percent and twelve factors in the 2020 report)—including physical inactivity, hypertension, diabetes, obesity, smoking, excessive alcohol, depression, social isolation, hearing loss, traumatic brain injury, air pollution, low education, untreated vision loss, and high LDL cholesterol. The question is whether this theoretical potential translates into practical interventions that people will actually adopt.

Siette, Dodds, and Deckers (2024) test this translation with BRAIN BOOTCAMP, a low-intensity multidomain intervention targeting diet, exercise, cognitive activity, and social interaction in Australian older adults. The pilot study finds that even a brief, community-based program can measurably improve dementia risk scores and increase dementia literacy. The "low-intensity" design is deliberate: previous trials like FINGER (Finnish Geriatric Intervention Study) demonstrated efficacy with intensive, resource-heavy protocols, but real-world implementation requires programs that are affordable, scalable, and accessible to populations without research-grade support infrastructure. BRAIN BOOTCAMP's innovation is showing that risk reduction is achievable without the full FINGER protocol—simpler programs with fewer contact hours can still shift behavior and improve risk profiles, at least in the short term. The limitation is durability: whether brief interventions produce lasting behavioral change remains an open question.

Tainta, Ecay-Torres, and Barandiaran (2025) describe the CITA GO-ON study, a community-based multidomain intervention inspired by the FINGER model but adapted to a Basque Country population. Their protocol combines physical exercise, cognitive training, dietary counseling (emphasizing the Mediterranean diet), and social engagement activities, delivered through community health centers rather than research facilities. The study's design addresses a critical gap in the field: most dementia prevention trials recruit highly motivated, well-educated volunteers who may not represent the broader at-risk population. By embedding the intervention in existing community infrastructure, CITA GO-ON aims to reach participants who would never enroll in a university-based research trial, testing whether the FINGER model's benefits translate to real-world, diverse populations.

Mehrabadi and Barati (2025) provide the mechanistic foundation, reviewing how genetic, lifestyle, and epigenetic factors interconnect in brain aging. Their comprehensive review identifies exercise as the single lifestyle factor with the strongest neuroprotective evidence, operating through multiple mechanisms: enhanced cerebral blood flow, neurogenesis in the hippocampus, reduction of neuroinflammation, and improved clearance of amyloid-beta through the glymphatic system. Diet operates through overlapping but partially distinct pathways—anti-inflammatory effects, gut-brain axis modulation, and provision of neuroprotective nutrients. Social engagement appears to build cognitive reserve—the brain's ability to maintain function despite accumulating pathology—through sustained cognitive stimulation that maintains neural network complexity. The review also highlights an important epigenetic dimension: lifestyle factors can modify gene expression patterns associated with neurodegeneration, meaning that behavioral choices do not merely compensate for genetic risk but can partially reprogram it.

The convergence of these studies supports cautious optimism: cognitive decline is not an inevitable consequence of aging, and practical interventions exist to slow it. The remaining challenge is population-level implementation—moving from successful pilots to national prevention programs that reach the millions of older adults who stand to benefit most.

With no disease-modifying drug for Alzheimer's yet proven effective at scale, the prevention paradigm for cognitive decline has shifted toward modifiable lifestyle factors. The 2024 Lancet Commission on Dementia updated its estimate to up to 45 percent of dementia cases that could theoretically be delayed or prevented by addressing fourteen modifiable risk factors (up from 40 percent and twelve factors in the 2020 report)—including physical inactivity, hypertension, diabetes, obesity, smoking, excessive alcohol, depression, social isolation, hearing loss, traumatic brain injury, air pollution, low education, untreated vision loss, and high LDL cholesterol. The question is whether this theoretical potential translates into practical interventions that people will actually adopt.

Siette, Dodds, and Deckers (2024) test this translation with BRAIN BOOTCAMP, a low-intensity multidomain intervention targeting diet, exercise, cognitive activity, and social interaction in Australian older adults. The pilot study finds that even a brief, community-based program can measurably improve dementia risk scores and increase dementia literacy. The "low-intensity" design is deliberate: previous trials like FINGER (Finnish Geriatric Intervention Study) demonstrated efficacy with intensive, resource-heavy protocols, but real-world implementation requires programs that are affordable, scalable, and accessible to populations without research-grade support infrastructure. BRAIN BOOTCAMP's innovation is showing that risk reduction is achievable without the full FINGER protocol—simpler programs with fewer contact hours can still shift behavior and improve risk profiles, at least in the short term. The limitation is durability: whether brief interventions produce lasting behavioral change remains an open question.

Tainta, Ecay-Torres, and Barandiaran (2025) describe the CITA GO-ON study, a community-based multidomain intervention inspired by the FINGER model but adapted to a Basque Country population. Their protocol combines physical exercise, cognitive training, dietary counseling (emphasizing the Mediterranean diet), and social engagement activities, delivered through community health centers rather than research facilities. The study's design addresses a critical gap in the field: most dementia prevention trials recruit highly motivated, well-educated volunteers who may not represent the broader at-risk population. By embedding the intervention in existing community infrastructure, CITA GO-ON aims to reach participants who would never enroll in a university-based research trial, testing whether the FINGER model's benefits translate to real-world, diverse populations.

Mehrabadi and Barati (2025) provide the mechanistic foundation, reviewing how genetic, lifestyle, and epigenetic factors interconnect in brain aging. Their comprehensive review identifies exercise as the single lifestyle factor with the strongest neuroprotective evidence, operating through multiple mechanisms: enhanced cerebral blood flow, neurogenesis in the hippocampus, reduction of neuroinflammation, and improved clearance of amyloid-beta through the glymphatic system. Diet operates through overlapping but partially distinct pathways—anti-inflammatory effects, gut-brain axis modulation, and provision of neuroprotective nutrients. Social engagement appears to build cognitive reserve—the brain's ability to maintain function despite accumulating pathology—through sustained cognitive stimulation that maintains neural network complexity. The review also highlights an important epigenetic dimension: lifestyle factors can modify gene expression patterns associated with neurodegeneration, meaning that behavioral choices do not merely compensate for genetic risk but can partially reprogram it.

The convergence of these studies supports cautious optimism: cognitive decline is not an inevitable consequence of aging, and practical interventions exist to slow it. The remaining challenge is population-level implementation—moving from successful pilots to national prevention programs that reach the millions of older adults who stand to benefit most.